Found: 26
Select item for more details and to access through your institution.
Clostridioides difficile Infection: Clinical Practice and Health Outcomes in 6 Large Tertiary Hospitals in Eastern Australia.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 6, p. 1, doi. 10.1093/ofid/ofad232
- By:
- Publication type:
- Article
Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase–Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 8, p. 1, doi. 10.1093/ofid/ofab387
- By:
- Publication type:
- Article
Shewanella spp. Bloodstream Infections in Queensland, Australia.
- Published in:
- Emerging Infectious Diseases, 2022, v. 28, n. 4, p. 701, doi. 10.3201/eid2804.212193
- By:
- Publication type:
- Article
Aspergillus Species Causing Invasive Fungal Disease in Queensland, Australia.
- Published in:
- Mycopathologia, 2023, v. 188, n. 3, p. 211, doi. 10.1007/s11046-023-00713-5
- By:
- Publication type:
- Article
Pasteurella species bloodstream infections in Queensland, Australia, 2000–2019.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2022, v. 41, n. 4, p. 609, doi. 10.1007/s10096-022-04411-w
- By:
- Publication type:
- Article
Scedosporium species and Lomentospora prolificans fungaemia is uniformly fatal in patients with haematological malignancy.
- Published in:
- Internal Medicine Journal, 2023, v. 53, n. 8, p. 1489, doi. 10.1111/imj.16198
- By:
- Publication type:
- Article
Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID‐19: a systematic review.
- Published in:
- Internal Medicine Journal, 2022, v. 52, n. 4, p. 522, doi. 10.1111/imj.15432
- By:
- Publication type:
- Article
Sexually acquired reactive arthritis secondary to macrolide‐resistant Mycoplasma genitalium urethritis.
- Published in:
- Internal Medicine Journal, 2022, v. 52, n. 2, p. 332, doi. 10.1111/imj.15684
- By:
- Publication type:
- Article
Cryptococcus neoformans infection as a cause of severe hyperammonaemia and encephalopathy.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Listeria monocytogenes brain abscess as a late complication of allogeneic haemopoietic stem cell transplantation.
- Published in:
- Internal Medicine Journal, 2021, v. 51, n. 6, p. 1005, doi. 10.1111/imj.15356
- By:
- Publication type:
- Article
Acute kidney injury in acute Q fever.
- Published in:
- Internal Medicine Journal, 2019, v. 49, n. 10, p. 1326, doi. 10.1111/imj.14447
- By:
- Publication type:
- Article
Consumer perspectives on simplified, layered consent for a low risk, but complex pragmatic trial.
- Published in:
- Trials, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13063-022-07023-z
- By:
- Publication type:
- Article
An Update on the Laboratory Diagnosis of Rickettsia spp. Infection.
- Published in:
- Pathogens, 2021, v. 10, n. 10, p. 1319, doi. 10.3390/pathogens10101319
- By:
- Publication type:
- Article
Completing the Picture—Capturing the Resistome in Antibiotic Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 12, p. e1122, doi. 10.1093/cid/ciaa1877
- By:
- Publication type:
- Article
Modern Clinician-initiated Clinical Trials to Determine Optimal Therapy for Multidrug-resistant Gram-negative Infections.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 2, p. 433, doi. 10.1093/cid/ciz1132
- By:
- Publication type:
- Article
Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales ("MERINO-3"): study protocol for a multicentre, open-label randomised non-inferiority trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial.
- Published in:
- JAC-Antimicrobial Resistance, 2022, v. 4, n. 1, p. 1, doi. 10.1093/jacamr/dlab192
- By:
- Publication type:
- Article
Outbreaks of Fungal Infections in Hospitals: Epidemiology, Detection, and Management.
- Published in:
- Journal of Fungi, 2023, v. 9, n. 11, p. 1059, doi. 10.3390/jof9111059
- By:
- Publication type:
- Article
An Australian perspective on antimicrobial stewardship programs and transplantation.
- Published in:
- Transplant Infectious Disease, 2022, v. 24, n. 5, p. 1, doi. 10.1111/tid.13912
- By:
- Publication type:
- Article
Infectious complications of CAR T-cell therapy: a clinical update.
- Published in:
- Therapeutic Advances in Infectious Disease, 2021, v. 8, p. 1, doi. 10.1177/20499361211036773
- By:
- Publication type:
- Article
Comparison of Low‐Level to High‐Level Disinfection in Eliminating Microorganisms From Ultrasound Transducers Used on Skin: A Noninferiority Randomized Controlled Trial.
- Published in:
- Journal of Ultrasound in Medicine, 2023, v. 42, n. 11, p. 2525, doi. 10.1002/jum.16286
- By:
- Publication type:
- Article
Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 8, p. 2040, doi. 10.1093/jac/dkae209
- By:
- Publication type:
- Article
An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa--authors' response.
- Published in:
- 2021
- By:
- Publication type:
- Letter
An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Erratum to: Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections.
- Published in:
- 2020
- By:
- Publication type:
- journal article